← Eichor
Condition: Chronic Kidney Disease Stages 4 And 5 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Kidney Disease Stages 4 And 5

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Agenda-Setting for Kidney Disease Open Pilot Trial
NA · 2 location(s) · Dartmouth-Hitchcock Medical Center · NCT07221604ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Phase 4 · 1 location(s) · Ace Cells Lab Limited · NCT07187713Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease
Phase 3 · 1 location(s) · Ain Shams University · NCT06982079Kidney Transplant Improvement Through New Exercise Training to Increase Capacity
NA · 1 location(s) · University of Pennsylvania · NCT07446296Assessment of Protein Intake Using 2 Types of Nutritional Collection in Chronic Kidney Disease.
Phase N/A · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06224153Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease
NA · 1 location(s) · Massachusetts General Hospital · NCT07186218Canagliflozin in Advanced Renal Disease With MRI Endpoints
Phase 2 · 1 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06182839A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinic
NA · 1 location(s) · The University of Hong Kong · NCT06799936Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
NA · 1 location(s) · Vanderbilt University Medical Center · NCT07385651Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients
NA · 1 location(s) · Hospital Universitario Dr. Jose E. Gonzalez · NCT07694791Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellit
NA · 1 location(s) · Well Cell Global · NCT07187479BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06741072
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.